What constitutes controlled hypertension? Patient based comparison of hypertension guidelines

BMJ

Volumn 313, Issue 7049, 1996, Pages 93-96

  Fahey, T P ^a   Peters, T J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CANADA; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; GENERAL PRACTICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NEW ZEALAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK; RISK BENEFIT ANALYSIS; SAMPLING; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION;

AGED; ANTIHYPERTENSIVE AGENTS; CANADA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; GREAT BRITAIN; HUMANS; HYPERTENSION; MIDDLE AGED; NEW ZEALAND; PRACTICE GUIDELINES; RISK; UNITED STATES;

EID: 0030054577     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7049.93     Document Type: Article

References (30)

1. Collins R, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD, ed. Textbook of hypertension. Oxford: Blackwell Scientific, 1994: 1156–64.
2. Jackson R, Barham P, Bills J, Birch T, McLennan I, MacMahon S. et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ 1993; 307: 107–110.
3. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J. et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306: 983–987.
4. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154–183.
5. Subcommittee of WHO/ISH Mild Hypertension Liaison Committee. Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. BMJ 1993; 307: 1541–6.
6. Meyers MG, Carruthers SG, Leenen FHH, Haynes RB. Recommendations from the Canadian Hypertension Society consensus conference on the pharmacologic treatment of hypertension. Can Med Assoc J 1989; 140: 1141–6.
7. Swales J. Guidelines on guidelines. J Hypertens 1993; 11: 899–903.
8. Davey Smith G, Egger M. Who benefits from medical interventions? BMJ 1994; 308: 72–74.
9. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomised trials. JAMA 1994; 272: 1932–8.
10. Alderman MH. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119: 329–335.
11. Sackett D, Cook R. Understanding clinical trials. BMJ 1994; 309: 755–756.
12. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. BMJ 1990; 300: 981–983.
13. Fahey T, Lancaster T. The detection and management of hypertension in the elderly of Northamptonshire. J Public Health Med 1995; 17: 57–62.
14. Levy D. Have expert panel guidelines kept pace with new concepts in hypertension? Lancet 1995; 346: 1112.
15. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford: Blackwell Scientific, 1987.
16. Donner A, Birkett N, Buck C. Randomization by cluster. Am J Epidemiol 1981; 114: 906–914.
17. Donner A, Klar N. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 1994; 140: 279–289.
18. Grol R. Implementing guidelines in general practice care. Quality in Health Care 1992; 1: 184–191.
19. Croog S, Levine S, Testa M, Brown B, Bulpitt C, Jenkins D. et al. The effects of antihypertensive therapy on quality of life. N Engl J Med 1986; 314: 1657–64.
20. Hoes A, Grobbee D, Lubsen J. Does drug treatment improve survival? Reconciling the trials in mild to moderate hypertension. J Hypertens 1995; 13: 805–811.
21. Egger M, Davey Smith G. Risks and benefits of treating mild hypertension: a misleading meta-analysis? J Hypertens 1995; 13: 813–815.
22. Swales J. Pharmacological management of hypertension. Lancet 1994; 344: 380–385.
23. Grover S, Coupal L, Hu X-P. Identifying adults at increased risk of coronary disease: how well do cholesterol guidelines work? JAMA 1995; 274: 801–806.
24. Dahlof B, Lindholm L, Hansson L, Schersten B, Ekbom T, Wester P. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 1991; 338: 1281–4.
25. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405–412.
26. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255–64.
27. Hayward R, Wilson M, Tunis S, Bass E, Guyatt G. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A: are the recommendations valid? JAMA 1995; 274: 570–574.
28. Payer L. Medicine and culture. Varieties of treatment in the United States, England, West Germany and France. 1st ed. New York: Henry Holt, 1988.
29. Evans JS, Harries C, Dennis I, Dean J. General practitioners' tacit and stated policies in the prescription of lipid lowering agents. Br J Gen Pract 1995; 45: 15–18.
30. Grover S, Lowensteyn I, Esrey K, Steinert Y, Joseph L, Abrahamowicz M. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ 1995; 310: 975–978.